申请人:Kontani Toru
公开号:US20060229295A1
公开(公告)日:2006-10-12
There is provided a pharmaceutical drug, particularly a novel compound useful for prophylaxis or a therapeutic treatment of various diseases involving infections with viruses of the herpesvirus family, specifically various herpesvirus infections such as varicella (chicken pox) via varicella zoster virus, varicella zoster via recurrent infection with latent varicella zoster virus, herpes labialis and herpes encephalitis via HSV-1 and genital herpes via HSV-2 infection. An N-2-[(4-substituted phenyl)amino]-2-oxoethyl}tetrahydro-2H-thiopyran-4-carboxamide derivative, of which phenyl group is substituted at position 4 with a specific 5- or 6-membered heteroaryl group, and a salt thereof have an effective anti-virus activity, and the oral administration thereof at a low dose enabled the therapeutic treatment of the above diseases.
提供了一种药物,特别是一种新型化合物,可用于预防或治疗涉及疱疹病毒家族感染的各种疾病,特别是各种疱疹病毒感染,如水痘(通过水痘带状疱疹病毒)、带状疱疹(通过潜伏水痘带状疱疹病毒的复发感染)、单纯疱疹病毒性口唇炎和单纯疱疹病毒性脑炎(通过HSV-1)以及生殖器疱疹(通过HSV-2感染)。一种N-2-[(4-取代苯基)氨基]-2-氧乙基}四氢-2H-硫吡喃-4-羧酰胺衍生物,其中苯基在4位被特定的5-或6-成员杂环基取代,以及其盐具有有效的抗病毒活性,其口服低剂量治疗上述疾病。